Research & Academia
Breakthroughs, publications and the frontier of discovery.
Latest Research & Academia news
October: Discovery of chicken immune cells and effective poultry vaccines | News and features
Read at University of Bristol →Psychological Stress Triggers Arthritis Flares in Mice via IL-6-Dependent Pathway
Read at Genetic Engineering and Biotechnology News →Ultima UG200 Chosen for 80,000-Sample UK Biobank Immune Study
Read at Unite.AI →IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease
Read at Business Wire →A Microfluidic Bacterial Display Platform Reimagines Protein Engineering
Read at The Scientist →From the knowledge base
ASHG: Long-Read Genomics Meets Clinical Data in PacBio, Verily Health AI Deal
A multi-year collaboration will connect PacBio's HiFi sequencing with Verily Pre, combining long-read genomic and clinical data for biomedical research and AI model development.
5 iced coffees we're bringing to a job interview
A viral post sparked debate around the professionalism of iced coffee. Explore the gallery for our five natural iced coffee picks sure to impress.
It will take more than data to improve traceability in the cotton supply chain
New research supported by Cotton Diaries explores the idea of "relational traceability" and making farmers a key source of intel.
Former MIT professor David Sabatini awarded $6M in defamation case
A Massachusetts jury awarded $6 million in damages to prominent biologist David Sabatini, years after sexual harassment allegations led to his ouster from MIT. Roughly five years ago, Sabatini brought the
How this plastic-free personal care brand tackles men's reproductive health
Learn about Old Salt Grooming's plastic-free product line paired with broader messaging around men's reproductive health and the environmental cost of personal care.
Antheia gets $80M conditional DOD loan to onshore to the US
Biosynthesis manufacturer Antheia has won a conditional loan of $80 million from the US Department of Defense to help boost the domestic production of generic drugs. "Over time, we aim to manufacture Antheia's full pipeline ...